Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis
- PMID: 31732227
- DOI: 10.1016/j.ophtha.2019.09.032
Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis
Abstract
Purpose: To determine the age- and sex-specific prevalence and incidence of demyelinating optic neuritis and the risk of multiple sclerosis (MS) in pediatric and adult populations in South Korea.
Design: A nationwide, population-based, retrospective study using data from the Korean National Health Claims database from 2010 to 2016.
Participants: The entire South Korean population aged 65 years of age or younger (n = 44 700 564). All patients with optic neuritis from the entire Korean population were included.
Methods: Patients aged 14 years of age or younger were classified as pediatric patients, and those aged 15 to 65 years were classified as adults. Each group was analyzed separately. Patients with optic neuritis had a subsequent diagnosis, including idiopathic, MS, neuromyelitis optica (NMO), and acute disseminated encephalomyelitis. Prevalence and incidence, conversion rate to MS, and treatment modalities (steroids, plasmapheresis, interferon-β, and immunosuppressants) were estimated.
Main outcome measures: Prevalence and incidence of optic neuritis, and conversion rate to MS.
Results: Among 44 700 564 individuals, 531 pediatric patients (50.7% female) and 7183 adults (53.3% female) were identified as having optic neuritis. Annual incidence was 1.04 (95% confidence interval [CI], 1.01-1.07) per 100 000 pediatric individuals and 3.29 (95% CI, 3.28-3.30) per 100 000 adults. Peak incidence was observed at 10 to 14 years in the pediatric population and at 30 to 34 years and 50 to 54 years in the adult population. Conversion rate to MS was 13.8% in the pediatric population and 11.4% in the adult population. Fourteen percent of all patients were treated with chronic immunosuppressants, 38% of patients with NMO underwent plasmapheresis, and 50% of patients with MS were treated with interferon-β.
Conclusions: This is a nationwide epidemiologic study of optic neuritis in individuals of all ages in South Korea. The incidence of optic neuritis and subsequent risk of MS in the pediatric population are comparable to those reported in western countries but are lower in the adult population than in western countries. The incidence rate in adults was 3.2-fold higher than in the pediatric population, and the overall MS conversion rate in the entire Korean population was estimated to be 10.6%.
Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Epidemiology of pediatric multiple sclerosis, neuromyelitis optica, and optic neuritis in Taiwan.J Neurol. 2020 Apr;267(4):925-932. doi: 10.1007/s00415-019-09647-9. Epub 2019 Nov 28. J Neurol. 2020. PMID: 31781928
-
Changes in the Incidence of Optic Neuritis before and after the Coronavirus Disease 2019 Outbreak: A Nationwide Study 2017-2022.Ophthalmology. 2025 Mar;132(3):280-289. doi: 10.1016/j.ophtha.2024.09.009. Epub 2024 Sep 13. Ophthalmology. 2025. PMID: 39278270
-
Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea.Korean J Ophthalmol. 2019 Feb;33(1):82-90. doi: 10.3341/kjo.2018.0050. Korean J Ophthalmol. 2019. PMID: 30746915 Free PMC article.
-
Pediatric Optic Neuritis.Semin Pediatr Neurol. 2017 May;24(2):122-128. doi: 10.1016/j.spen.2017.04.004. Epub 2017 Apr 10. Semin Pediatr Neurol. 2017. PMID: 28941527 Review.
-
Optic neuritis.Eye (Lond). 2011 Jul;25(7):833-42. doi: 10.1038/eye.2011.81. Epub 2011 Apr 29. Eye (Lond). 2011. PMID: 21527960 Free PMC article. Review.
Cited by
-
Bilateral Optic Neuritis after COVID-19 Vaccination: A Case Report.Vaccines (Basel). 2022 Nov 9;10(11):1889. doi: 10.3390/vaccines10111889. Vaccines (Basel). 2022. PMID: 36366396 Free PMC article.
-
Risk of Autoimmune Diseases Following Optic Neuritis: A Nationwide Population-Based Cohort Study.Front Med (Lausanne). 2022 Jun 13;9:903608. doi: 10.3389/fmed.2022.903608. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35770018 Free PMC article.
-
Current Advances in Pediatric Onset Multiple Sclerosis.Biomedicines. 2020 Mar 28;8(4):71. doi: 10.3390/biomedicines8040071. Biomedicines. 2020. PMID: 32231060 Free PMC article. Review.
-
Central alterations of brain networks in patients with optic neuritis: a resting state fMRI study.Int J Ophthalmol. 2025 Mar 18;18(3):469-477. doi: 10.18240/ijo.2025.03.14. eCollection 2025. Int J Ophthalmol. 2025. PMID: 40103952 Free PMC article.
-
Risk of central nervous system demyelinating attack or optic neuritis recurrence after pediatric optic neuritis in Korea.Neurol Sci. 2024 Mar;45(3):1173-1183. doi: 10.1007/s10072-023-07125-9. Epub 2023 Oct 19. Neurol Sci. 2024. PMID: 37853292
MeSH terms
LinkOut - more resources
Full Text Sources
Medical